ArticleInternational journal of clinical oncology2021

The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study.

Taigo Kato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.